INTREPID: single-<i>versus</i>multiple-inhaler triple therapy for COPD in usual clinical practice

Abstract

In a usual clinical care setting, treatment with once-daily single-inhaler FF/UMEC/VI resulted in significantly more patients gaining health status improvement and greater lung function improvement <i>versus</i> non-ELLIPTA MITT.